136 results
8-K
EX-99.1
MTEM
Molecular Templates Inc
26 May 23
Molecular Templates to Present on Phase I Dose Escalation Study of MT-6402 at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
5:16pm
EXHIBIT 99.1
Molecular Templates to Present on Phase I Dose Escalation Study of MT-6402 at the 2023 American Society of Clinical Oncology (ASCO … Society of Clinical Oncology (“ASCO”) Annual Meeting, taking place June 2-6, 2023 in Chicago, IL. One-on-one meetings may be scheduled directly
8-K
EX-99.1
MTEM
Molecular Templates Inc
15 May 23
Molecular Templates, Inc. Reports First Quarter 2023 Financial Results and Business Update
4:49pm
a poster on updated clinical data on MT-6402 (ETB targeting PD-L1), June 3, 2023, at the 2023 American Society for Clinical Oncology (ASCO) Annual
8-K
EX-99.1
g89x5malun0vua8y2
10 Nov 22
Molecular Templates, Inc. Reports Third Quarter 2022 Financial Results
4:30pm
8-K
i2n pvqeds14
10 Nov 22
Molecular Templates, Inc. Reports Third Quarter 2022 Financial Results
4:30pm
8-K
EX-99.2
8m9 d26yh022r
10 Nov 22
Molecular Templates, Inc. Reports Third Quarter 2022 Financial Results
4:30pm
8-K
EX-99.1
c1r dr681eq9ve1
11 Aug 22
Molecular Templates, Inc. Reports Second Quarter 2022 Financial Results
4:10pm
8-K
EX-99.1
kwk 3uwxb79p9
12 May 22
Molecular Templates, Inc. Reports First Quarter 2022 Financial Results
12:00am
8-K
EX-99.1
u7jfii1
15 Nov 21
Molecular Templates, Inc. Reports Third Quarter 2021 Financial Results
7:30am